Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

MedImmune adds VPs

  • News

Executive Summary

MedImmune promotes three employees to newly created VP posts: Cynthia Oliver to VP of process biochemistry and formulation sciences; Kripa Ram to VP of bioprocess and manufacturing sciences; and Mark Schenerman to VP of analytical biochemistry. The company also hires Jessie Groothuis as VP and head of medical & scientific affairs, infectious disease. She will be responsible for the late-stage clinical programs for MedImmune's marketed infectious disease products, such as Synagis (palivizumab) and FluMist...

Table

View full table

Tags:
Latest Headlines

Bolar Exemption India Files: Roche Blocks Alleged Infringer Of Evrysdi Patent

First Do No Harm: US MedPAC Wrestles With Complexity Of Low-Cost Drug Pricing

JNJ, BMS’s IRA Loss First Time Court Rejects Industry’s First Amendment, Takings Claims

EU Launches Critical Medicines Alliance But Prospect Of Act On Manufacturing Still Uncertain

See All
UsernamePublicRestriction

Register

PS047828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By